1. Home
  2. NC vs ACIU Comparison

NC vs ACIU Comparison

Compare NC & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NACCO Industries Inc.

NC

NACCO Industries Inc.

HOLD

Current Price

$38.66

Market Cap

300.7M

Sector

Energy

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$2.68

Market Cap

247.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NC
ACIU
Founded
1913
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.7M
247.6M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
NC
ACIU
Price
$38.66
$2.68
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
15.1K
180.6K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
N/A
EPS
1.04
N/A
Revenue
$104,778,000.00
N/A
Revenue This Year
N/A
$706.75
Revenue Next Year
N/A
$321.13
P/E Ratio
$38.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.69
$2.10
52 Week High
$59.42
$4.00

Technical Indicators

Market Signals
Indicator
NC
ACIU
Relative Strength Index (RSI) 29.23 49.62
Support Level N/A $2.57
Resistance Level $44.04 $2.68
Average True Range (ATR) 1.25 0.13
MACD -0.11 -0.02
Stochastic Oscillator 1.25 19.05

Price Performance

Historical Comparison
NC
ACIU

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments: Utility Coal Mining, Contract Mining, and Minerals and Royalties. The Utility Coal Mining segment, operated by North American Coal, manages surface coal mines that are exclusive, long-term fuel providers for power generation companies. The Contract Mining segment, operated by North American Mining, is a provider of a broad range of specialized, long-term contract mining services. The Minerals and Royalties segment, which includes the Catapult Mineral Partners (Catapult) business, acquires and promotes the development of mineral and royalty interests and other related investments.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: